These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15390219)

  • 1. Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
    Corrao G; Botteri E; Bagnardi V; Zambon A; Carobbio A; Falcone C; Leoni O
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):31-40. PubMed ID: 15390219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical-Bayes adjustment improved conventional estimates in postmarketing drug-safety studies.
    Bagnardi V; Botteri E; Corrao G
    J Clin Epidemiol; 2006 Nov; 59(11):1162-8. PubMed ID: 17027426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the effect of transient exposure on the risk of acute events by means of time-window designs: an application to fluoroquinolone antibacterials and arrhythmia.
    Corrao G; Botteri E; Bertù L; Zambon A; Favilli S
    Pharmacoepidemiol Drug Saf; 2006 Jan; 15(1):31-7. PubMed ID: 15954079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis.
    Tsiropoulos I; Andersen M; Hallas J
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):483-91. PubMed ID: 19326363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.
    Clark DW; Layton D; Wilton LV; Pearce GL; Shakir SA
    Drug Saf; 2001; 24(15):1143-54. PubMed ID: 11772147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.
    Zambon A; Polo Friz H; Contiero P; Corrao G
    Drug Saf; 2009; 32(2):159-67. PubMed ID: 19236122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy.
    Salvo F; Polimeni G; Moretti U; Conforti A; Leone R; Leoni O; Motola D; Dusi G; Caputi AP
    J Antimicrob Chemother; 2007 Jul; 60(1):121-6. PubMed ID: 17449881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
    Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
    Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
    Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
    Gagne JJ; Maio V; Rabinowitz C
    J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study to build a database on seven anti-hypertensive drugs.
    Fujita T; Miura Y; Mayama T
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):41-6. PubMed ID: 15534857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea.
    Cho Y; Park HS
    BMJ Open; 2018 Sep; 8(9):e020974. PubMed ID: 30269062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Danish prescription registries.
    Gaist D; Sørensen HT; Hallas J
    Dan Med Bull; 1997 Sep; 44(4):445-8. PubMed ID: 9377907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diplopia and fluoroquinolones.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs.
    Hebert C; Delaney JA; Hemmelgarn B; Lévesque LE; Suissa S
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):845-9. PubMed ID: 17563091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs.
    Corrao G; Zambon A; Faini S; Bagnardi V; Leoni O; Suissa S
    J Clin Epidemiol; 2005 Jan; 58(1):92-7. PubMed ID: 15649676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.